A PHASE I STUDY OF CONTINUOUS AMBULATORY INTRAVENOUS INFUSION OF DOCETAXEL IN WO

多西紫杉醇连续门诊静脉输注的I期研究

• 批准号: 7605998
• 负责人: LEVI S. DOWNS
• 金额: $ 1.76万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7605998
• 关键词: Adverse reactions; Computer Retrieval of Information on Scientific Projects Database; Count; Funding; Grant; Institution; Intravenous; Malignant Female Reproductive System Neoplasm; Monitor; Patients; Phase; Phase I Clinical Trials; Physicians; Pump; Recurrence; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Woman; blood treatment; day; docetaxel; intravenous administration

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Phase I study of continuous ambulatory intravenous infusion of docetaxel in women with progressive or recurrent gynecologic cancer. Patients will receive docetaxel through an I-Flow pump connected to an existing intravenous line of the physician's choosing. Docetaxel will be adminstered via the pump continuously for a maximum of 180 days. Patients will be closely monitored throughout treatment by blood counts and assessment of adverse reactions.

这个子项目是众多研究子项目之一